The Treato IQ Plataform will connect pharmaceutical companies with Hispanic conumers

Treato IQ by Treato will now evaluate Hispanic population’s perception, providing a new and valuable resource for pharmaceutical companies that wish to collaborate with the growing Hispanic community.Many organizations wish to approach the Hispanic community because it is the only demographic segment that comprises approximately 53 million people in the US.”Talking about personal problems, such as health, is more comfortable to do in your mother tongue, and for the bicultural Hispanic community, this often means sharing the Spanish language online”, said Ido Hadari, CEO of Treato. “When providing information or messages in Spanish in forums and blogs related with health, pharmaceutical companies can understand consumers, which will enable better results”.According to Pew Research Center and Forrester Research, 80% of Hispanic users active in the Internet frequently enters social networks. Besides, Hispanics have twice the likelihood than their non-Hispanic counterparts of being content creators and writing comments on articles of any sort.This new corporate intelligence that IQ Treato offers allows pharmaceutical companies to analyze specific situations or experiences related with the Hispanic market’s health, which will help them add value to this key segment that is constantly growing.To know more details about this initiative, enter {Corp Treato;http://corp.treato.com/}.